Pharma Company

topic on 2 shows · 2 statements across 2 episodes

the a16z Podcast TBPN

2 statements about Pharma Company, every show

TBPN Opinion
Sadeghi: 23andMe cannot develop drugs using microarray genetic data
“They really viewed data gathering as a means to make drugs, but because it's such a small sliver of your DNA, you actually can't really make drugs off of it”
Kian Sadeghi Mar 25, 2025 ▶ 3:02 Kian Sadeghi on 23andMe’s Collapse and the Rise of Nucleus Genomics.
a16z Insight
Pharma Demands Manufacturing Control Unless Assets Require Specialized Know-How
“If the asset is very critical to the business the pharma company will In all likelihood, want to control the manufacturing and distribution unless it is a very niche specialized product like gene therapies and AAVs, which require specialized know-how.”
Koki Hirasaki Feb 28, 2019 ▶ 20:33 What’s with All the Bio M&A in 2019?: A Quick Take

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.